Lufax Discloses RMB 7 Billion in Undisclosed Related-Party Loans and Internal Control Deficiencies
Summary
Lufax Holding Ltd disclosed key findings from a supplemental investigation, revealing RMB 7.0 billion in previously undisclosed related-party loans used to acquire distressed assets, alongside internal control deficiencies and non-consolidated entities. Trading remains suspended on the Hong Kong Stock Exchange.
Key Events
-
Undisclosed Related-Party Loans Revealed
A supplemental investigation found that Lufax extended approximately RMB 7.0 billion (approximately $970 million USD) in loans to a third party (Xechang Investment) between June 2020 and January 2023, which were used to acquire distressed assets, effectively bringing them under the Company's de facto control.
-
Improper Accounting Treatment
The accounting treatment for these related-party loan transactions, used for compensatory purposes, failed to reflect their true economic substance, indicating a material misrepresentation of financial activities.
-
Non-Consolidated Controlled Entities
The investigation identified three entities, including two held by Xechang Investment, that were controlled by Lufax but whose financial statements were not consolidated into the Company's financials.
-
Internal Control Deficiencies Identified
An independent internal control review by Deloitte Consulting identified deficiencies, for which the Company is implementing remedial measures, with a follow-up review underway.
Analysis
This 6-K filing reveals significant issues for Lufax Holding Ltd, including previously undisclosed related-party loans totaling RMB 7.0 billion (approximately $970 million USD) to an entity that then acquired distressed assets, effectively bringing them under the Company's de facto control. The accounting treatment for these transactions was deemed improper, failing to reflect their economic substance. Furthermore, the Company identified three controlled entities whose financials were not consolidated. These findings, coupled with ongoing internal control reviews and the continued suspension of trading on the Hong Kong Stock Exchange, indicate serious governance and financial reporting concerns. While operational highlights for Q4 2025 show mixed results (decrease in total outstanding loans, increase in consumer finance loans, decrease in new loans enabled, but improved NPL ratios), the core issues of undisclosed related-party transactions and accounting irregularities are highly material and point to a significant negative impact on investor confidence and regulatory standing.
At the time of this filing, LU was trading at $2.66 on NYSE in the Finance sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $2.25 to $4.57. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.